A comparative analysis exposes an amplification delay distinctive to SARS-CoV-2 Omicron variants of clinical and public health relevance

References

• Davies NG, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021 Apr 9;372(6538).
   Web of Science ®Google Scholar
• Volz E, Mishra S, Chand M, et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature. 2021;593(7858):266–269.
   PubMed Web of Science ®Google Scholar
• Wang P, Nair MS, Liu L, et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature. 2021;593(7857):130–135.
   PubMed Web of Science ®Google Scholar
• Janik E, Niemcewicz M, Podogrocki M, et al. The emerging concern and interest SARS-CoV-2 variants. Pathogens. 2021 May 21;10(6.
   Web of Science ®Google Scholar
• Robishaw JD, Alter SM, Solano JJ, et al. Genomic surveillance to combat COVID-19: challenges and opportunities. Lancet Microbe. 2021;2(9):e481–e484.
   PubMedGoogle Scholar
• Msomi N, Mlisana K, de Oliveira T, et al. A genomics network established to respond rapidly to public health threats in South Africa. Lancet Microbe. 2020;1(6):e229–e230.
   PubMedGoogle Scholar
• Ceci A, Munoz-Ballester C, Tegge AN, et al. Development and implementation of a scalable and versatile test for COVID-19 diagnostics in rural communities. Nat Commun. 2021;12(1):4400.
   PubMed Web of Science ®Google Scholar
• Valley-Omar Z, Marais G, Iranzadeh A, et al. Reduced amplification efficiency of the RNA-dependent-RNA-polymerase target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests. J Virol Methods. 2022 Apr;302:114471.
   PubMed Web of Science ®Google Scholar
• Brown KA, Gubbay J, Hopkins J, et al. S-Gene target failure as a marker of variant B.1.1.7 Among SARS-CoV-2 isolates in the greater Toronto area, December 2020 to March 2021. JAMA. 2021 May 25;325(20):2115–2116.
   PubMed Web of Science ®Google Scholar
• Erster O, Mendelson E, Levy V, et al. Rapid and high-throughput reverse transcriptase quantitative PCR (RT-qPCR) assay for identification and differentiation between SARS-CoV-2 variants B.1.1.7 and B.1.351. Microbiol Spectr. 2021 Oct 31;9(2):e0050621.
   PubMed Web of Science ®Google Scholar
• Wright ES, Yilmaz LS, Ram S, et al. Exploiting extension bias in polymerase chain reaction to improve primer specificity in ensembles of nearly identical DNA templates. Environ Microbiol. 2014;16(5):1354–1365.
   PubMed Web of Science ®Google Scholar
• Network A. SARS-CoV-2 V4.1 update for Omicron variant 2021. Available from: https://community.artic.network/t/sars-cov-2-v4-1-update-for-omicron-variant/342.
   Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):45e.
   PubMed Web of Science ®Google Scholar
• Untergasser A, Ruijter JM, Benes V, et al. Web-based LinRegPCR: application for the visualization and analysis of (RT)-qPCR amplification and melting data. BMC Bioinformatics. 2021;22(1):398.
   PubMed Web of Science ®Google Scholar
• Cameroni E, Bowen JE, Rosen LE, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature. 2022;602(7898):664–670.
   PubMed Web of Science ®Google Scholar
• Cao Y, Wang J, Jian F, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602(7898):657–663.
   PubMed Web of Science ®Google Scholar
• Liu L, Iketani S, Guo Y, et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature. 2022;602(7898):676–681.
   PubMed Web of Science ®Google Scholar
• Planas D, Saunders N, Maes P, et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2022;602(7898):671–675.
   PubMed Web of Science ®Google Scholar
• McCallum M, Czudnochowski N, Rosen LE, et al. Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement. Science. 2022;375(6583):864–868.
   PubMed Web of Science ®Google Scholar
• Whiley DM, Sloots TP. Sequence variation in primer targets affects the accuracy of viral quantitative PCR. J Clin Virol. 2005;34(2):104–107.
   PubMed Web of Science ®Google Scholar
• Lefever S, Pattyn F, Hellemans J, et al. Single-nucleotide polymorphisms and other mismatches reduce performance of quantitative PCR assays. Clin Chem. 2013;59(10):1470–1480.
   PubMed Web of Science ®Google Scholar
• Noguera DR, Wright ES, Camejo P, et al. Mathematical tools to optimize the design of oligonucleotide probes and primers. Appl Microbiol Biotechnol. 2014;98(23):9595–9608.
   PubMed Web of Science ®Google Scholar
• Vogels CBF, Brito AF, Wyllie AL, et al. Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets. Nat Microbiol. 2020;5(10):1299–1305.
   PubMed Web of Science ®Google Scholar
• Schmidt F, Muecksch F, Weisblum Y, et al. Plasma neutralization of the SARS-CoV-2 Omicron variant. N Engl J Med. 2022;386(6):599–601.
   PubMed Web of Science ®Google Scholar
• Andrews N, Stowe J, Kirsebom F, et al. COVID-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532–1546.
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Stella AO, Walker G, et al. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia. Nat Microbiol. 2022;7(6):896–908.
   PubMed Web of Science ®Google Scholar